X

    Xylem Inc (XYL)

    Official site

    INDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE

    $110.15
    -1.16 (-1.04%)

    Market Cap: $25.99B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    93%(37/40)
    Avg Surprise
    +6.45%
    Streak
    25 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$1.45
    Range$1.41 - $1.53
    20 analysts
    EPS Revisions
    3
    0
    7d
    5
    11
    30d
    EPS Estimate Drift
    90d ago$1.46+0.1%
    60d ago$1.46+0.1%
    30d ago$1.46+0.3%
    7d ago$1.45+0.0%
    Current$1.45
    Revenue Consensus
    $2.3B
    Range$2.3B - $2.3B
    19 analysts
    Dec 31, 2026
    EPS Consensus$1.79
    Range$1.71 - $1.87
    22 analysts
    Revenue Consensus
    $2.5B
    Range$2.4B - $2.6B
    21 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.79---
    Sep 26EST
    		-$1.45---
    Jun 26
    		$1.46$1.34+8.96%Beat+15.9%
    Mar 26
    		$1.12$1.08+3.70%Beat+8.7%
    Dec 25
    		$1.42$1.41+0.71%Beat+20.3%
    Sep 25
    		$1.37$1.23+11.38%Beat+23.4%
    Jun 25
    		$1.26$1.15+9.57%Beat+15.6%
    Mar 25
    		$1.03$0.95+8.42%Beat+14.4%
    Dec 24
    		$1.18$1.13+4.42%Beat+19.2%
    Sep 24
    		$1.11$1.11+0.00%Beat+12.1%
    Jun 24
    		$1.09$1.05+3.81%Beat+11.2%
    Mar 24
    		$0.90$0.84+7.14%Beat+25.0%
    Dec 23
    		$0.99$0.95+4.21%Beat+7.6%
    Sep 23
    		$0.99$0.89+11.24%Beat+25.3%
    Jun 23
    		$0.98$0.81+20.99%Beat+48.5%
    Mar 23
    		$0.72$0.62+16.13%Beat+53.2%
    Dec 22
    		$0.92$0.79+16.46%Beat+46.0%
    Sep 22
    		$0.79$0.66+19.70%Beat+25.4%
    Jun 22
    		$0.66$0.54+22.22%Beat+0.0%
    Mar 22
    		$0.47$0.43+9.30%Beat-16.1%
    Dec 21
    		$0.63$0.61+3.28%Beat-22.2%
    Sep 21
    		$0.63$0.60+5.00%Beat+1.6%
    Jun 21
    		$0.66$0.63+4.76%Beat+65.0%
    Mar 21
    		$0.56$0.37+51.35%Beat+143.5%
    Dec 20
    		$0.81$0.68+19.12%Beat-9.0%
    Sep 20
    		$0.62$0.50+24.00%Beat-24.4%
    Jun 20
    		$0.40$0.38+5.26%Beat-49.4%
    Mar 20
    		$0.23$0.37-37.84%Miss-55.8%
    Dec 19
    		$0.89$0.89+0.00%Beat+1.1%
    Sep 19
    		$0.82$0.82+0.00%Beat+6.5%
    Jun 19
    		$0.79$0.79+0.00%Beat+8.2%
    Mar 19
    		$0.52$0.56-7.14%Miss+2.0%
    Dec 18
    		$0.88$0.88+0.00%Beat+15.8%
    Sep 18
    		$0.77$0.77+0.00%Beat+18.5%
    Jun 18
    		$0.73$0.71+2.82%Beat+23.7%
    Mar 18
    		$0.51$0.52-1.92%Miss+30.8%
    Dec 17
    		$0.76$0.76+0.00%Beat+15.2%
    Sep 17
    		$0.65$0.64+1.56%Beat+20.4%
    Jun 17
    		$0.59$0.57+3.51%Beat-
    Mar 17
    		$0.39$0.38+2.63%Beat-
    Dec 16
    		$0.66$0.65+1.54%Beat-
    Sep 16
    		$0.54$0.53+1.89%Beat-

    Dividends

    Dividend Metrics

    Yield1.53%
    Annual/Share$1.69
    Payout Ratio30.69%
    Frequency4
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+10.06%
    5Y CAGR+9.00%
    View XYL's full dividend history

    Key Metrics

    Valuation
    P/E Ratio20.51EV/EBITDA15.09x
    Price/FCF27.11xFCF Yield3.69%
    Profitability
    Profit Margin11.20%Operating Margin17.00%
    ROE9.18%ROIC7.70%
    Financial Health
    Debt/Equity0.28xInterest Coverage56.35x
    Current Ratio1.61xQuick Ratio1.24x
    Trading Statistics
    Beta1.01Avg Volume1.59M
    52-Week High$152.1452-Week Low$104.48

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$112.85
    SMA 20$116.66
    SMA 50$117.58
    SMA 200$124.28
    EMA 10$113.21
    EMA 20$115.11
    EMA 50$116.37
    EMA 200$121.85

    MACD

    Line: -1.97Signal: -1.21Hist: -0.76

    ADX

    ADX: 22.4+DI: 14.7-DI: 27.5

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$119.31

    Bollinger Bands

    Upper Band$125.04
    Lower Band$108.28
    %B Position1436%(Upper)
    Band Width0.11

    RSI (14-Day)

    Neutral
    35.2

    Momentum Oscillators

    Stoch %K7.0
    Stoch %D7.6
    Williams %R-98.9
    ROC (10d)-5.9%
    Momentum-6.87
    CCI (20d)-115.7
    MFI (14d)19.9

    Volatility Measures

    ATR (14d)$2.87(2.6%)
    StdDev (20d)4.19
    Hist Vol22.7%(Moderate)

    Volume Flow

    VWAP$110.48
    OBV191.2K
    AD Line-621.1M
    CMF (20d)-0.532

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio1.2x
    VWMA (20d)$116.25

    Pivot Points

    R3$116.45
    R2$115.08
    R1$113.19
    Pivot Point$111.83
    S1$109.94
    S2$108.57
    S3$106.69

    Advanced Oscillators

    TSI-17.27
    Ultimate Osc25.9
    KST-47.21

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.34B$2.13B$2.40B$2.27B$2.30B$2.07B$2.26B$2.10B$2.17B$2.03B$2.12B$2.08B
    Cost of Revenue$1.37B$1.32B$1.47B$1.39B$1.41B$1.30B$1.40B$1.32B$1.35B$1.28B$1.36B$1.31B
    Gross Profit$963.00M$803.00M$932.00M$883.00M$892.00M$768.00M$857.00M$784.00M$819.00M$752.00M$756.00M$764.00M
    Operating Expenses$573.00M$559.00M$579.00M$549.00M$587.00M$537.00M$590.00M$504.00M$566.00M$543.00M$545.00M$573.00M
    R&D$59.00M$56.00M$60.00M$52.00M$58.00M$56.00M$58.00M$55.00M$58.00M$59.00M$60.00M$61.00M
    SG&A$503.00M$472.00M$486.00M$474.00M$503.00M$460.00M$507.00M$445.00M$485.00M$474.00M$466.00M$491.00M
    Operating Income$390.00M$244.00M$353.00M$334.00M$305.00M$231.00M$267.00M$280.00M$253.00M$209.00M$211.00M$191.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$7.00M$4.00M$6.00M$6.00M$9.00M$8.00M$9.00M$10.00M$11.00M$14.00M$14.00M$14.00M
    Income Before Tax$364.00M$244.00M$368.00M$297.00M$299.00M$217.00M$375.00M$269.00M$247.00M$196.00M$210.00M$185.00M
    Income Tax Expense$103.00M$55.00M$35.00M$71.00M$75.00M$50.00M$49.00M$52.00M$53.00M$43.00M$-56,000,000$33.00M
    Net Income$261.00M$189.00M$333.00M$226.00M$224.00M$167.00M$326.00M$217.00M$194.00M$153.00M$266.00M$152.00M
    EBITDA$511.00M$388.00M$517.00M$445.00M$453.00M$370.00M$374.00M$420.00M$403.00M$344.00M$361.00M$346.00M
    EBIT$371.00M$248.00M$374.00M$303.00M$308.00M$225.00M$232.00M$279.00M$258.00M$210.00M$224.00M$199.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Own The Future: What You Need To Know About The Next 1, 5, and 50 Years To Thrive In The World That's Coming

    The most important earnings day in history is April 29th (Wed) when AMZN, MSFT, META, and GOOG announce (all hyperscale's at once) Earnings from TSMC, SK Hynix, and ASML prove that AI demand is still far above supply. Hyperscale's are going to report strong earnings, and likely higher capex. NVDA gets 50% of their capex spend with 55% FCF margins and 90% FCF/share growth this year (100% if China approves Hopper sales). Still Has 92% Upside Potential Left This Year. Economy is still strong at 2.8% growth BUT corporate profit growth keeps accelerating. 18% CAGR for S&P and 20% for Nasdaq (FCF) growth, 4X historical norms. PEGY analysis of the S&P and Nasdaq shows the S&P is 17% undervalued and Nasdaq 22% (both near bear market low valuations with explosive growth). S&P has 40% upside potential (after 14% rally) due to explosive growth and Nasdaq upside potential is 52%. This week's in-depth research (Chairman memos) provide updates for WTRG thesis and much deeper look into the Choke Points for the future of everything investment thesis. XYL is my favorite water opportunity, but TSM, ASML, and AVGO are likely to find their way into ZEUS...which is running in the top 10/100,000 simulations (on track for 44% year this year)

    Unknown Author
    •
    4/24/26
    •
    826
    Technical Analysis
    Mega-Cap Technology
    Also mentions:
    MSFT
    TSM
    ASML
    AVGO
    AMZN

    Government Contracts

    Gov Obligations (TTM)
    $83545
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    2
    New Awards (TTM)
    2
    Avg Remaining Term
    0.3 mo

    Top agency: Department of Justice at 57.1% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    15B21526P00000070Department of JusticeFederal Prison System / Bureau of Prisons$24875Aug 14, 2026
    15B21526P00000043Department of JusticeFederal Prison System / Bureau of Prisons$22831Feb 4, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Bill Grogan Appointed Chief Financial Officer at GE HealthCare

    Bill Grogan has been appointed as the new Chief Financial Officer (CFO) at GE HealthCare, bringing over 25 years of finance and business leadership experience. He previously held CFO roles at Xylem and IDEX Corporation and served on the Board of Directors at Crane NXT. Grogan's extensive background in financial strategy, planning, treasury, and operational finance will be instrumental in his new role at the global healthcare technology company.

    https://hrtoday.in/•8/31/26•
    Neutral

    Xylem stock steadies as dividend date approaches and Q2 beat supports guidance

    Xylem Inc. stock is holding steady around $112 as its ex-dividend date of August 27, 2026, approaches, bolstered by a strong Q2 2026 earnings beat that supports its full-year guidance. Despite recent fluctuations, the company maintains a "Moderate Buy" consensus rating and a target price of $155.00, suggesting significant upside potential for investors. Institutional investors are actively increasing their positions, indicating confidence in Xylem's valuation and its role in smart water infrastructure solutions.

    Ad-hoc-news.de•8/26/26•
    Bullish

    Xylem stock steadies after Q2 beat and dividend update

    Xylem Inc. (XYL) stock is holding steady after reporting a Q2 earnings beat, with EPS of $1.46 against an estimated $1.34, and reaffirming its FY 2026 EPS guidance. The company also declared a $0.43 quarterly dividend. With a market capitalization of $26.66 billion, analysts maintain a $155 target for the water technology company.

    Ad-hoc-news.de•8/25/26•
    Bullish

    What Could GE HealthCare Technologies (GEHC) Gain From Its New CFO?

    GE HealthCare Technologies has appointed William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan's background in large acquisitions and portfolio repositioning aligns with GE HealthCare's growth strategy in diagnostics and digital solutions. His role will be crucial in balancing capital deployment between R&D, deals, and potential buybacks, influencing the company's long-term investment narrative.

    Simply Wall Street•8/25/26•
    Neutral

    What Could GE HealthCare Technologies (GEHC) Gain From Its New CFO?

    GE HealthCare Technologies has appointed William K. Grogan as its new Chief Financial Officer, effective September 14, 2026. Grogan's background in large acquisitions and portfolio repositioning aligns with GE HealthCare's growth strategy focusing on partnerships and diagnostics. His role will be crucial in managing capital deployment, tariff exposure, and the company's debt while supporting its long-term diagnostics and AI narrative.

    Simply Wall Street•8/25/26•
    Neutral

    Frequently Asked Questions About XYL

    What is XYL's current dividend yield?
    Xylem Inc (XYL) has a current dividend yield of 1.53%.
    Does XYL pay dividends?
    Yes, Xylem Inc pays dividends with a current yield of 1.53%.
    What is XYL's P/E ratio?
    Xylem Inc has a price-to-earnings (P/E) ratio of 20.51.
    What is XYL's market cap?
    Xylem Inc (XYL) has a market capitalization of $25.99B with a current stock price of $110.15.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In